The WisdomTree Floating Rate Treasury Fund ETF (USFR) is rated a Buy due to its low credit and duration risk in a hawkish monetary policy environment. It offers a 30-day SEC yield of about 4.01%, closely tracking short-term Treasury rates, making it attractive for conservative investors seeking tactical flexibility as market uncertainty persists. However, historically low floating rate note spreads and widening investment-grade credit spreads suggest some caution. Overall, USFR provides a stable income option amid volatile equity markets and fluctuating Treasury yields.
The WisdomTree Floating Rate Treasury Fund ETF (USFR) is discussed here as a near-term, low-risk tactical cash allocation. For readers following US stocks on Pluang, here is the market snapshot as of Nov 10, 2026 16:02 WIB: out of 150 priced US stocks, 77 rose and 68 fell. Notable movers include BCS (Barclays PLC) at USD 23.60 with a 1-day change of +1.77% and a typical hold time of 63 days, LCID (Lucid Group Inc) at USD 3.54 down -1.67% with a 46-day hold time, and FCEL (FuelCell Energy Inc) at USD 10.65 down -1.57%, with Pluang order activity showing 68% Sell and 32% Buy, and a typical hold time of 49 days.
The global paracetamol market is projected to grow from $12.05 billion in 2026 to $15.39 billion by 2032, with a CAGR of 4.12%. Growth is driven by increasing demand for pain and fever management, expanded access to over-the-counter medicines, and in...
ESET Research uncovered a sophisticated cyberespionage tool named Cereal, used by the Russia-aligned Turla group to spy on emails within Microsoft Exchange servers of governmental organizations in Kazakhstan and Romania. The tool stealthily collects ...
Registration is now open for Brand Licensing Expo 2027, scheduled for May 25-27 at Mandalay Bay, Las Vegas. The event, rebranded from Licensing Expo, features over 265 confirmed exhibitors including major brands like Amazon MGM Studios, Coca-Cola, an...
Trogenix, a clinical-stage precision oncology company, has appointed John Young as Chair and Josh Murray as Non-Executive Director to support its global strategy, commercial growth, and US expansion. John Young brings over 35 years of pharmaceutical ...
Wellington Management Group LLP has notified that it crossed the 5% voting rights threshold in Admiral Group PLC as of November 6, 2026. The group holds a total of 5.01% voting rights through direct shares and financial instruments. This disclosure i...
